Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
212.50    -2.00 (-0.93%)
Bid:
210.00
Ask:
215.00
Spread: 5.00 (2.381%)
Market Cap: £145.12m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

Company Announcement

29 May 2025 07:03

RNS Number : 5052K
Helios Underwriting Plc
29 May 2025
Β 

29 May 2025

Helios Underwriting PLC

Β 

("Helios" or the Company)

Β 

Company announcement

Helios, the only publicly traded company offering instant access to a diverse portfolio of syndicates at Lloyd's of London, announces that Adhiraj Maitra will take on the new role of Director of Finance and Operations, after the AGM in June, following the retirement of Arthur Manners, Finance Director. The Board will consider the appointment of Adhiraj to the Board after the AGM.

Arthur Manners will leave the Company after the AGM in June, retiring after 10 years, in which he has been a careful custodian of Helios' financial health.

Adhiraj joined Helios as Chief Operating Officer (COO) from Canopius in March 2024, and has been involved in the Group's portfolio restructuring, materially reducing the Company's underwriting risk, gearing and overall cost base for 2025. Over his 18-year career, Adhiraj has built experience across a breadth of technical and leadership roles including five years with Lloyd's heading up the syndicate capital team, and four years with Willis Towers Watson leading the capital and risk initiatives in the London Market.

John Chambers, Interim Executive Chairman commented:

"Having been invaluable in helping guide Helios through a period of significant growth and successful delivery as COO, Adhiraj possesses a deep understanding of the business that makes him the natural choice of Director of Finance and Operations. Adhiraj exemplifies one of Helios' key differentiators: deep data driven market insights and knowledge of Lloyd's that we can leverage on behalf of clients. We look forward to continuing working with him in this new capacity as we continue to prioritise shareholder returns and active cycle management. On behalf of the Board, I would like to thank Arthur for his significant contribution to the success of the Company over 10 years and wish him well in his retirement."

Adhiraj Maitra, commented:

"I will continue to work with Arthur for a smooth transition and am delighted to accept the role as the Director of Finance and Operations, starting 1 July 2025, at this exciting point for Helios and the London Market. Helios offers a very attractive entry point for value investors seeking to access a profitable pipeline of Lloyd's results, and I look forward to continuing to work alongside John and the Board as we maximise Helios capital strength and agility to maximise these significant investment opportunities."

Β 

Β 

For further information, please contact:

Helios Underwriting plc

John Chambers - Interim Executive Chairman

Arthur Manners - Chief Financial Officer

44 (0)203 965 6441

Deutsche Numis (Nomad and Broker)

Giles Rolls / Charles Farquhar +44 (0)20 7260 1000

FTI Consulting

Ed Berry +44 (0)7703 330 199

Nathan Hambrook-Skinner +44 (0)7977 817 092

Christian Harte +44 (0)7974 288 763

Β 

Β 

Β 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market. The portfolio provides a broad spread of business primarily participating in the US and other international wholesale and reinsurance markets. For further information please visitΒ www.huwplc.com

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAUWRARVUUVUUR
Date   Source Headline
8th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20264:05 pmRNSGrant of LTIP Award
5th Jun 20267:00 amRNSGrant of LTIP Awards
1st Jun 20267:00 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSNotice of AGM
26th May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSFinal Results for the year ended 31 December 2025
18th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTR-1 announcement
11th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTotal Voting Rights
27th Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTR-1: Acquisition of Voting Rights
21st Apr 20267:00 amRNSChange of Nominated Adviser
20th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20265:17 pmRNSHolding(s) in Company
10th Apr 20267:00 amRNSDirector/PDMR Shareholding
9th Apr 20267:00 amRNSQuarterly Syndicate Mid-point Forecast update
20th Jan 20267:00 amRNS2026 YOA Portfolio Update
9th Jan 20267:00 amRNSAppointment of Chief Underwriting Officer
4th Dec 20255:42 pmRNSGrant of LTIP Awards
2nd Dec 20257:00 amRNSNet Asset Value(s)
13th Nov 20251:32 pmRNSDirector/PDMR Shareholding
13th Nov 20251:30 pmRNSDirector/PDMR Shareholding
7th Nov 202510:10 amRNSHolding(s) in Company
6th Nov 20251:51 pmRNSDirector/PDMR Shareholding
5th Nov 20255:48 pmRNSTR1 - Change in breakdown of voting rights
30th Oct 20257:00 amRNSResult of Tender Offer
24th Oct 202512:20 pmRNSResults of General Meeting
21st Oct 20257:01 amRNSDirector Appointments
21st Oct 20257:00 amRNSCapital Markets Day
29th Sep 20257:01 amRNSProposed Tender Offer and Notice of GM
29th Sep 20257:00 amRNSHalf Year Results
19th Sep 20257:00 amRNSAppointment of Chief Executive Officer
1st Sep 20253:37 pmRNSDirector/PDMR Shareholding
29th Aug 202512:52 pmRNSPDMR Dealing
28th Aug 20252:16 pmRNSDirector/PDMR Shareholding
26th Aug 20257:00 amRNSQuarterly Syndicate Mid-point Forecasts
1st Aug 20257:00 amRNSTotal Voting Rights
31st Jul 202512:12 pmRNSTR-1: Notification of major holdings
18th Jul 20257:00 amRNSResults of Scrip Dividend Election
9th Jul 20259:45 amRNSResults of Scrip Dividend Election
30th Jun 20255:40 pmRNSAppointment of Executive Director
30th Jun 202512:28 pmRNSResult of AGM
30th Jun 20257:00 amRNSChange of Nominated Adviser
20th Jun 20259:32 amRNSScrip Dividend Reference Price
9th Jun 20251:15 pmRNSLTIP Exercise and Total Voting Rights Update
9th Jun 20251:15 pmRNSGrant of LTIP Awards

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.